Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study

Fig. 3

Number and severity of maximal phototoxic episodes before and during treatment with afamelanotide. For the number and severity of phototoxic episodes during treatment we assessed the preceding 2 months and considered only values, when the time interval since the last dose did not exceed 80 days

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172